Profile data is unavailable for this security.
About the company
PT Soho Global Health Tbk is an Indonesia-based company. The Company operates in the healthcare sector. The Company operates through five segments: Distribution, Professional product, Consumer health, Alliance, and Others. Its brands include Curcuma Plus, Curcuma Plus Milk, Imboost, Fitkom, Diapet, Laxing, Lelap, Asthma Soho and Sohobion. Curcuma Plus is a kid’s multivitamin that contains curcuma and fish oil. Curcuma Plus Milk is a growing up milk for kids. Imboost is a supplement that supports immune system. Fitkom offers kids multivitamins in gummy and tablet format. Diapet is an anti-diarrheal medicine. Laxing is a medicine for healthy digestion and bowel movement. Lelap is a medicine to alleviate sleep disorders. Asthma Soho is an asthma remedy. Sohobion is a neurotropic vitamin supplement to maintain neurological health. The Company's product portfolio ranged from wound care, hospital general care, surgery, orthopedics, and in-vitro diagnostics.
- Revenue in IDR (TTM)8.58tn
- Net income in IDR440.54bn
- Incorporated--
- Employees2.37k
- LocationSoho Global Health Tbk PTJalan Jend. Sudirman Kav 27Mayapada 2 Building, 12th FloorJakarta 12920IndonesiaIDN
- Phone+62 2 146832588
- Fax+62 2 146832589
- Websitehttps://sohoglobalhealth.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hanshang Group Co Ltd | 3.03tn | 110.25bn | 5.91tn | 2.38k | 52.84 | 1.54 | -- | 1.95 | 0.1707 | 0.1707 | 4.65 | 5.84 | 0.3705 | 2.75 | 8.35 | 573,421.20 | 1.16 | 2.00 | 1.92 | 3.89 | 58.35 | 57.24 | 3.13 | 4.89 | 0.3366 | 2.15 | 0.3198 | 15.03 | 0.1893 | 5.14 | -32.24 | 25.62 | 12.88 | -- |
| Dishman Carbogen Amcis Ltd | 4.96tn | -296.58bn | 5.95tn | 1.30k | -- | -- | 21.01 | 1.20 | -9.84 | -9.84 | 164.35 | -- | -- | -- | -- | 19,919,850.00 | -- | 0.4699 | -- | 0.5665 | 76.93 | 74.36 | -5.98 | 1.82 | -- | -0.1245 | -- | 202.76 | 12.72 | 7.32 | -265.46 | -- | 21.54 | -- |
| Ginwa Enterprise Group Inc | 1.27tn | -52.46bn | 5.96tn | 553.00 | -- | 1.66 | -- | 4.68 | -0.0633 | -0.0633 | 1.53 | 4.32 | 0.2988 | 4.74 | 5.64 | 1,036,046.00 | -1.23 | 0.3641 | -1.44 | 0.4141 | 75.60 | 73.64 | -4.12 | 1.15 | 3.33 | 0.3439 | 0.0206 | 124.25 | -2.41 | -5.37 | -228.19 | -- | 61.66 | -- |
| Adimmune Corp | 884.14bn | -316.93bn | 6.01tn | 564.00 | -- | 2.18 | -- | 6.80 | -1.52 | -1.52 | 4.24 | 12.99 | 0.1916 | 2.32 | 1.94 | -- | -8.26 | 0.6867 | -9.86 | 0.7739 | 23.02 | 30.11 | -43.13 | 3.04 | 2.34 | -18.72 | 0.3523 | 32.80 | -20.72 | 16.77 | -319.91 | -- | 38.05 | -- |
| Beijing Succeeder Technology Inc | 632.21bn | 268.32bn | 6.07tn | 296.00 | 22.62 | 1.67 | -- | 9.60 | 1.14 | 1.14 | 2.68 | 15.36 | 0.1711 | 2.39 | 9.52 | 961,290.60 | 7.26 | 7.77 | 7.63 | 8.25 | 62.48 | 61.03 | 42.43 | 38.34 | 14.58 | -- | 0.00007 | 22.22 | 20.40 | 6.60 | 12.29 | 15.57 | 99.03 | -- |
| Gufic BioSciences Ltd | 1.51tn | 161.88bn | 6.15tn | 1.63k | 36.99 | -- | 30.32 | 4.08 | 8.62 | 8.62 | 80.38 | -- | -- | -- | -- | 4,820,074.00 | -- | 12.30 | -- | 23.08 | 51.08 | 44.91 | 10.73 | 9.84 | -- | 8.22 | -- | 1.39 | -11.36 | 17.47 | -16.84 | 37.06 | 86.82 | 14.87 |
| Zhejiang Cheng Yi Pharmaceutical Co Ltd | 1.50tn | 346.24bn | 6.25tn | 738.00 | 17.97 | 2.30 | -- | 4.15 | 0.4781 | 0.4781 | 2.07 | 3.74 | 0.3666 | 1.92 | 11.71 | 917,147.40 | 8.40 | 12.01 | 10.14 | 14.75 | 63.88 | 69.79 | 22.92 | 22.84 | 1.21 | -- | 0.2589 | 36.44 | 2.54 | 4.24 | 0.8129 | 10.94 | -23.56 | 12.84 |
| Soho Global Health Tbk PT | 8.58tn | 440.54bn | 6.32tn | 2.37k | 14.35 | 2.50 | 12.42 | 0.7363 | 34.71 | 34.71 | 676.37 | 198.99 | 1.77 | 5.67 | 4.97 | 3,617,495,000.00 | 9.06 | 7.97 | 16.53 | 14.37 | 16.24 | 19.39 | 5.13 | 4.65 | 1.26 | -- | 0.006 | -- | 12.45 | 12.43 | 4.10 | 49.70 | 21.21 | -- |
